Market revenue in 2023 | USD 710.9 million |
Market revenue in 2030 | USD 1,255.0 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.77% in 2023. Horizon Databook has segmented the Spain home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Bank Group, the country’s population aged 65 & above accounted for nearly 19.1% of the total population in 2017 and around 19.6% in 2019. In addition, according to Cable News Network, Spain is projected to be one of the super-aged countries by 2030 with nearly 24.1% of its population above 65 years of age Rise in geriatric population is anticipated to boost the demand for long-term and home care services, thereby facilitating the market growth.
Moreover, according to European Commission Joint Report on Health Care and Long-Term Care Systems and Fiscal Sustainability, the percentage of dependents on long-term care in the country is anticipated to increase from 5.3% of the its population in 2013 to 8.6% in 2060, thereby fueling the market growth. Availability of social insurance for home care is expected to reduce the financial burden on patients, which is anticipated to increase the adoption of home infusion therapies, thereby boosting the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Spain home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account